Divi`s Laboratories` Market Capitalization

Snowflake IPO: A Rebound for the US Stock Market
Case Code: FINC183
Case Length: 8 Pages
Period: 2003-2021
Pub Date: 2021
Teaching Note: Available
Price: Rs.200
Organization: Divis Laboratories Limited
Industry: Pharmaceuticals & Biotech
Countries: India
Themes: Investment Decisions Investment Philosophy
Snowflake IPO: A Rebound for the US Stock Market
Abstract Case Intro 1 Case Intro 2 Excerpts


On December 17, 2020, India-based pharmaceutical company Divi’s Laboratories Limited (Divi’s) entered the elite club of companies with a Rs. 1 trillion market capitalization in the Indian stock exchanges (BSE and NSE). Divi’s was the second Pharma company in India after Sun Pharmaceutical Industries (Sun) to across the Rs. 1 trillion benchmark . Sun was valued at around Rs.1.4 trillion in December 2020, and Divi’s was valued at Rs. 1.01 trillion on the December 17, 2020, with a market price of Rs. 3,847.90 per share, surpassing its previous highest price of Rs. 3,763.40 recorded on December 10, 2020. (Refer to Exhibit I for List of the Companies having Market Capitalization of above Rs. 1 Trillion in India)..

Buy this case study (Please select any one of the payment options)

Price: Rs.200
Price: Rs.200
PayPal (5 USD)

Custom Search